Consistent with this notion, recent studies have found that expression of ROR1, a receptor of Wnt5a, was highly expressed by high-grade and less-differentiated ovarian cancers and associated with a relatively short disease-free survival and overall survival compared to ovarian cancers that did not express ROR1 [61–63]. This evidence concerns the gene ROR1 and ovarian cancer.